GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jacobio Pharmaceuticals Group Co Ltd (HKSE:01167) » Definitions » Net Margin %

Jacobio Pharmaceuticals Group Co (HKSE:01167) Net Margin % : -831.74% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Jacobio Pharmaceuticals Group Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Jacobio Pharmaceuticals Group Co's Net Income for the six months ended in Dec. 2023 was HK$-210.92 Mil. Jacobio Pharmaceuticals Group Co's Revenue for the six months ended in Dec. 2023 was HK$25.36 Mil. Therefore, Jacobio Pharmaceuticals Group Co's net margin for the quarter that ended in Dec. 2023 was -831.74%.

The historical rank and industry rank for Jacobio Pharmaceuticals Group Co's Net Margin % or its related term are showing as below:

HKSE:01167' s Net Margin % Range Over the Past 10 Years
Min: -565.36   Med: -349.83   Max: -197.1
Current: -565.36


HKSE:01167's Net Margin % is ranked worse than
66.7% of 1027 companies
in the Biotechnology industry
Industry Median: -151.78 vs HKSE:01167: -565.36

Jacobio Pharmaceuticals Group Co Net Margin % Historical Data

The historical data trend for Jacobio Pharmaceuticals Group Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jacobio Pharmaceuticals Group Co Net Margin % Chart

Jacobio Pharmaceuticals Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial - -311.27 -197.10 -388.38 -565.36

Jacobio Pharmaceuticals Group Co Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -173.03 -233.74 -594.36 -412.25 -831.74

Competitive Comparison of Jacobio Pharmaceuticals Group Co's Net Margin %

For the Biotechnology subindustry, Jacobio Pharmaceuticals Group Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jacobio Pharmaceuticals Group Co's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jacobio Pharmaceuticals Group Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Jacobio Pharmaceuticals Group Co's Net Margin % falls into.



Jacobio Pharmaceuticals Group Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Jacobio Pharmaceuticals Group Co's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-392.797/69.477
=-565.36 %

Jacobio Pharmaceuticals Group Co's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-210.922/25.359
=-831.74 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jacobio Pharmaceuticals Group Co  (HKSE:01167) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Jacobio Pharmaceuticals Group Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Jacobio Pharmaceuticals Group Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Jacobio Pharmaceuticals Group Co (HKSE:01167) Business Description

Traded in Other Exchanges
Address
No. 88, Kechuang 6th Street, Building F2, Beijing Economic-Technological Development Area, Beijing, CHN
Jacobio Pharmaceuticals Group Co Ltd is a clinical-stage pharmaceutical company focusing on the in-house discovery and development of innovative oncology therapies.
Executives
Shen Zhu 2501 Other
Treasure Partner International Limited 2501 Other
Ultimate Estate Limited 2201 Interest of corporation controlled by you
Wang Yinxiang 2501 Other
Wang Xiaojie 2307 Founder of a discretionary trust who can infl
Hu Yunyan 2501 Other
Yakovpharma Ltd 2501 Other
Willgenpharma Ltd 2501 Other
Risepharma Ltd 2101 Beneficial owner
Johwpharma Ltd 2501 Other
Hmed Ltd 2501 Other
Gloryviewpharma Ltd 2501 Other
Honourpharma Ltd 2501 Other
Blesspharma Ltd 2501 Other
Hillhouse Investment Management, Ltd. 2102 Investment manager

Jacobio Pharmaceuticals Group Co (HKSE:01167) Headlines

No Headlines